Cushing's Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 5 April 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Machine learning-assisted screening for canine Cushing's syndrome.
Yoo Young-Jae et al. — The veterinary quarterly (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/41431376/
- 2.
A rare case of ectopic cushing's syndrome caused by renal neuroendocrine tumor.
Sehatpour Faezeh et al. — Journal of diabetes and metabolic disorders (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41757383/
- 3.
Molecular and histopathological insights into renal neuroendocrine tumors (RenNETs): A comprehensive study.
Zhang Kaijian et al. — Pathology, research and practice (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41734604/
- 4.
Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion.
Araujo-Castro Marta et al. — Clinical endocrinology (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41298283/
- 5.
Cortisol measurement challenges in managing ectopic Cushing's syndrome with etomidate.
Brouwers Pauline et al. — Clinical chemistry and laboratory medicine (24 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41380673/
Clinical Trials — Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
Active (not recruiting) — Phase 2 — Pfizer
https://clinicaltrials.gov/study/NCT04649359
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Cushing's Syndrome
Cushing's Syndrome is a complex hormonal condition caused by prolonged exposure to high levels of cortisol, most commonly from a pituitary or adrenal tumour, or from long-term glucocorticoid medication. It is associated with central obesity, fragile skin, and serious metabolic complications. Diagnosis is notoriously difficult due to the wide variety of symptoms.
Most Recent Research
Cushing's syndrome (CS) is a common endocrine disorder in dogs that can significantly impair their quality of life. Diagnosis is often challenging because of its variable clinical presentation, making it difficult to identify suitable candidates for further diagnostic tests. This study employed machine learning algorithms to assist in CS diagnosis using routinely available screening diagnostics, including complete blood count, serum chemistry panel, and urinalysis parameters such as urine specific gravity and urine protein-to-creatinine ratio. Data were collected from 153 control dogs initially suspected of CS but later excluded and 152 dogs with confirmed CS. A boosted tree algorithm (gradient boosting) was trained on 80% of the collected data, with the remaining 20% reserved for testing. The developed model demonstrated an accuracy of 88.5% [95% confidence interval (CI): 80.5-96.5%], a sensitivity of 83.3% (95% CI: 70.7-96.7%), a specificity of 93.5% (95% CI: 84.9-100%), and an area under the receiver operating characteristic curve of 0.912 (95% CI: 0.835-0.988), indicating excellent discriminatory ability. A user-friendly graphical interface was also developed to facilitate clinical implementation, potentially improving diagnostic efficiency and owner satisfaction.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.